Data for A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis (Study ST000089)

(Analysis AN000141)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4F5F6F7
1-Hexadecanoyl-sn-glycero-3-phosphocholine NA NA NA NA NA 1.0479 0.9601
1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine 0.0281 0.0343 NA NA NA 2.3466 2.3003
1-Hexadecylpyridinium cation NA NA NA NA NA 0.0676 1.7770
1-Stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine 0.3222 0.3856 NA NA NA 1.8748 1.8915
Acetyl-L-carnitine NA NA NA NA NA 0.4443 1.4631
Acylcarnitine C16:0 NA NA NA NA NA 0.6993 1.2506
Acylcarnitine C18:0 NA NA NA NA NA 0.6958 1.2535
Acylcarnitine C18:1 NA NA NA NA NA 0.7391 1.2174
Benzyl dodecyl dimethylammonium cation (disinfectant) NA NA NA NA NA 0.9942 1.0048
Benzyl tetradecyl dimethylammonium cation (disinfectant) NA NA NA NA NA 1.0629 0.9476
C14:0 acylcarnitine NA NA NA NA NA 0.8083 1.1598
C16:1 acylcarnitine NA NA NA NA NA 0.8623 1.1147
CE (18:1) NA NA NA NA NA 1.2995 0.7504
CE (18:2) NA NA NA NA NA 1.0473 0.9527
Ceramide (d18:1/23:0) 0.8758 0.9583 NA NA NA 1.0298 1.1895
Ceramide (d40:1) 0.4663 0.5344 NA NA NA 1.5261 1.8164
Ceramide (d42:1) 0.2429 0.2753 NA NA NA 1.9936 2.0270
Ceramide (d42:2) NA NA NA NA NA 0.9261 1.0616
Cholesterol 1.0979 1.2120 0.0425 0.0393 NA 1.1863 1.2658
Choline NA NA NA NA NA 0.6268 1.3110
Creatine NA NA NA NA NA 0.0731 1.7724
DG (32:0) 0.9208 1.0906 NA NA NA NA NA
DG (34:1) 1.0727 1.2769 NA NA NA 0.7857 0.7587
DG (34:2) 0.8776 1.1399 NA NA NA NA NA
DG (36:2) 1.1091 1.3279 NA NA NA 0.6767 0.7414
DG (36:3) 1.5237 1.8359 NA NA NA 0.0540 0.1149
DG (36:4) 0.9163 1.0957 NA NA NA NA NA
DG (38:4) 0.4158 0.4941 NA NA NA 1.5043 1.9488
DG (38:5) 0.9074 1.1059 NA NA NA NA NA
GlcCer (40:1) NA NA NA NA NA 0.9880 1.0100
GlcCer (42:1) NA NA NA NA NA 1.0068 0.9943
GlcCer (42:2) NA NA NA NA NA 0.9800 1.0167
Hydromorphone (anesthetic) 0.9748 1.0288 NA NA NA NA NA
Lactosylceramide (d18:1/24:1(15Z)) NA NA NA NA NA 0.9844 1.0130
L-Carnitine NA NA NA NA NA 0.5805 1.3496
LPC (16:0) NA NA 0.1007 0.1227 NA 1.9071 1.7173
LPC (18:0) NA NA NA NA NA 0.9456 1.0453
LPC (18:1) NA NA NA NA NA 0.9663 1.0281
LPC (18:2) NA NA NA NA NA 0.8550 1.0725
LPC (20:4) NA NA NA NA NA 0.7955 1.1022
LPC-O (16:0) (plasmenyl or plasmanyl) NA NA NA NA NA 1.1001 0.9165
LPC-O (16:1) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0425 0.9646
LPC-O (18:1) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0969 0.9192
Lyso-PAF C-18 NA NA NA NA NA 1.0771 0.9358
N-(15Z-tetracosenoyl)-1-.beta.-galactosyl-sphing-4-enine NA NA NA NA NA 1.0203 0.9831
Niacinamide 0.1020 0.0862 NA NA NA 1.7104 2.6715
N-Stearoyl-4-sphingenyl-1-O-phosphorylcholine NA NA 0.9637 1.0134 1.0251 NA NA
N-Tetracosenoyl-4-sphingenyl-1-O-phosphorylcholine 0.0249 0.0260 0.0089 0.0078 0.0057 3.7000 3.8318
PC (16:0/16:0) 0.0418 0.0477 0.0102 0.0091 0.0030 3.6765 3.6351
PC (18:1/16:0) NA NA 0.0120 0.0103 0.0039 2.8308 2.9438
PC (28:0) NA NA NA NA NA 1.0916 0.9237
PC (30:0) 0.0257 0.0322 NA NA NA 2.4395 2.2286
PC (30:1) 0.0251 0.0268 NA NA NA 2.5053 2.1808
PC (31:0) 0.0167 0.0179 NA NA NA 2.5269 2.1844
PC (32:0) NA NA NA NA NA 0.9840 1.0133
PC (32:1) 0.0194 0.0221 NA NA NA 2.4059 2.2767
PC (32:2) 0.0303 0.0355 NA NA NA 2.3963 2.2546
PC (32:3) 0.0299 0.0382 NA NA NA 2.4444 2.2119
PC (33:0) 0.0367 0.0410 NA NA NA 2.3552 2.2739
PC (33:1) 0.0157 0.0182 NA NA NA 2.3221 2.3561
PC (33:2) 0.1033 0.1146 NA NA NA 2.1360 2.2819
PC (34:0) 0.0413 0.0432 NA NA NA 2.3187 2.2956
PC (34:1) 0.9219 1.0893 NA NA NA NA NA
PC (34:2) 0.4610 0.5599 0.0584 0.0651 0.0138 2.9678 3.9321
PC (34:3) 0.1256 0.1408 0.0395 0.0363 NA 2.5233 2.7009
PC (34:4) NA NA NA NA NA 0.8414 1.1322
PC (35:1) 0.0369 0.0406 NA NA NA 2.1771 2.4224
PC (35:2) 0.0397 0.0436 NA NA NA 2.2844 2.3259
PC (35:3) 0.1095 0.1345 NA NA NA 1.9408 2.4130
PC (36:1) 0.1572 0.1815 0.0478 0.0456 0.0277 3.6860 4.1990
PC (36:2) 0.1066 0.1253 0.0189 0.0202 0.0077 4.0495 4.1158
PC (36:3) A 0.2009 0.2349 0.0333 0.0379 0.0122 2.5098 4.7734
PC (36:4) 0.0587 0.0703 0.0347 0.0376 0.0295 3.2840 4.1707
PC (36:4) C NA NA NA NA NA 0.9522 1.0399
PC (36:5) NA NA NA NA NA 0.8961 1.0866
PC (36:5) C NA NA NA NA NA 0.8524 1.1230
PC (37:2) NA NA NA NA NA 1.6491 0.4591
PC (37:4) NA NA NA NA NA 0.9080 1.0767
PC (37:5) NA NA NA NA NA 0.8624 1.1147
PC (38:2) 0.0083 0.0085 NA NA NA 2.4619 2.2607
PC (38:3) NA NA 0.0285 0.0292 0.0288 2.6485 2.8635
PC (38:4) NA NA NA NA NA 0.9004 1.0830
PC (38:4) A 0.1620 0.1691 0.0479 0.0525 0.0430 3.6117 4.0835
PC (38:4) B 0.0413 0.0481 NA NA NA 2.1831 2.4029
PC (38:5) A 0.0385 0.0428 NA NA NA 2.1181 2.4669
PC (38:6) NA NA NA NA NA 1.0286 0.9762
PC (38:6) A 0.0241 0.0258 NA NA NA 2.3164 2.1781
PC (38:6) B 0.0456 0.0565 NA NA NA 1.5366 2.9261
PC (38:7) NA NA NA NA NA 1.0146 0.9878
PC (40:3) NA NA NA NA NA 1.0384 0.9680
PC (40:4) NA NA NA NA NA 1.0005 0.9996
PC (40:5) A NA NA 0.0988 0.0918 0.0932 2.1161 2.0319
PC (40:6) NA NA NA NA NA 0.9680 1.0267
PC (40:6) A NA NA NA NA NA 1.0639 0.9467
PC (40:6) B NA NA NA NA NA 0.9750 1.0208
PC (40:7) NA NA NA NA NA 1.0236 0.9803
PC (40:8) NA NA NA NA NA 0.8019 1.1651
PC (o-32:0) 0.9635 1.0417 NA NA NA NA NA
PC-O (32:0) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0291 0.9758
PC-O (32:1) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0236 0.9803
PC-O (34:0) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0357 0.9702
PC-O (34:1) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0116 0.9903
PC-O (34:2) -B (plasmenyl or plasmanyl) NA NA NA NA NA 1.0179 0.9851
PC-O (34:2) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0233 0.9805
PC-O (34:3) (plasmenyl or plasmanyl) NA NA NA NA NA 0.9148 1.0710
PC-O (36:2) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0173 0.9856
PC-O (36:3) (plasmenyl or plasmanyl) NA NA NA NA NA 0.8926 1.0895
PC-O (36:4) (plasmenyl or plasmanyl) NA NA NA NA NA 0.9420 1.0483
PC-O (36:5) (plasmenyl or plasmanyl) NA NA NA NA NA 0.9214 1.0655
PC-O (38:3) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0203 0.9831
PC-O (38:4) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0089 0.9926
PC-O (38:5) A (plasmenyl or plasmanyl) NA NA NA NA NA 0.9900 1.0083
PC-O (38:5) B (plasmenyl or plasmanyl) NA NA NA NA NA 1.0092 0.9924
PC-O (38:6) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0501 0.9582
PC-O (40:4) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0099 0.9917
PC-O (40:5) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0220 0.9817
PC-O (40:6) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0378 0.9685
PC-O (40:7) A (plasmenyl or plasmanyl) NA NA NA NA NA 1.0491 0.9591
PC-O (40:7) B (plasmenyl or plasmanyl) NA NA NA NA NA 0.9985 1.0013
PC-O (40:8) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0458 0.9618
PC-O (42:4) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0302 0.9748
PC-O (42:5) (plasmenyl or plasmanyl) NA NA NA NA NA 1.0264 0.9780
PC-O (44:5) (plasmenyl or plasmanyl) NA NA NA NA NA 0.9821 1.0149
PC (p-34:0) or PC (o-34:1) 0.9420 1.0663 NA NA NA NA NA
PC (p-34:1) or PC (o-34:2) A 0.9451 1.0628 NA NA NA NA NA
PC (p-34:2) or PC (o-34:3) 0.9149 1.0972 NA NA NA NA NA
PC (p-36:1) or PC (o-36:2) 0.9423 1.0659 NA NA NA NA NA
PC (p-36:2) or PC (o-36:3) 0.9246 1.0861 NA NA NA NA NA
PC (p-38:4) A or PC (o-38:5) A 1.0128 0.9854 NA NA NA NA NA
PC (p-38:5) or PC (o-38:6) 1.0161 0.9815 NA NA NA NA NA
PE (34:0) NA NA NA NA NA 1.0252 0.9790
PE (36:1) 0.9358 1.0734 NA NA NA NA NA
PE (36:4) NA NA NA NA NA 1.0248 0.9794
PE (36:5) NA NA NA NA NA 1.2787 0.7678
PE (38:4) 0.0167 0.0162 NA NA NA 2.3954 2.1321
PE-O (36:5) (plasmenyl or plasmanyl) NA NA NA NA NA 0.9539 1.0384
PE-O (38:5) (plasmenyl or plasmanyl) NA NA NA NA NA 0.9449 1.0459
PE-O (38:6) (plasmenyl or plasmanyl) NA NA NA NA NA 0.9718 1.0235
PE-O (40:6) (plasmenyl or plasmanyl) NA NA NA NA NA 0.9821 1.0149
PE (p-36:4) or PE (o-36:5) 0.9897 1.0117 NA NA NA NA NA
PE (p-38:4) or PE (o-38:5) 0.9997 1.0003 NA NA NA NA NA
plasmenyl-PC (34:2) 0.1512 0.1767 NA NA NA 1.8700 2.3672
plasmenyl-PE (34:1) 0.0305 0.0342 NA NA NA 2.3354 2.3067
plasmenyl-PE (34:2) 0.6696 0.8127 NA NA NA 1.2642 1.4388
plasmenyl-PE (36:1) 0.0909 0.1017 NA NA NA 2.1805 2.2763
plasmenyl-PE (36:2) 0.8656 1.1536 NA NA NA NA NA
plasmenyl-PE (38:1) NA NA NA NA NA 1.0037 0.9969
plasmenyl-PE (38:2) NA NA NA NA NA 1.0172 0.9857
plasmenyl-PE (38:3) NA NA NA NA NA 0.9824 1.0146
plasmenyl-PE (38:4) NA NA NA NA NA 0.9860 1.0117
plasmenyl-PE (38:5) 1.0146 0.9833 NA NA NA NA NA
plasmenyl-PE (40:4) NA NA NA NA NA 0.9635 1.0305
plasmenyl-PE (40:6) NA NA NA NA NA 1.0072 0.9940
PS (36:2) 0.0738 0.0892 NA NA NA 1.9682 2.1845
SM (32:1) NA NA NA NA NA 0.9939 1.0051
SM (33:1) 0.0511 0.0598 NA NA NA 2.0396 2.0242
SM (34:0) 0.0185 0.0197 NA NA NA 2.3324 2.3420
SM (34:1) 0.0097 0.0097 NA NA NA 2.3677 2.3360
SM (34:2) NA NA NA NA NA 1.0406 0.9661
SM (36:2) NA NA NA NA NA 0.9572 1.0357
SM (38:1) NA NA NA NA NA 0.9828 1.0144
SM (38:2) NA NA NA NA NA 1.0000 1.0000
SM (40:1) NA NA NA NA NA 1.0108 0.9910
SM (40:2) NA NA NA NA NA 0.9833 1.0139
SM (42:1) NA NA NA NA NA 1.0344 0.9713
SM (42:2) NA NA NA NA NA 1.0225 0.9813
SM (d16:1/20:0) 0.0669 0.0772 0.0238 0.0211 0.0141 3.3688 3.6293
SM (d16:1/20:1) NA NA NA NA NA 0.9776 1.0187
SM (d18:0/14:0) NA NA NA NA NA 0.9877 1.0103
SM (d18:1/14:0) 0.0522 0.0445 NA NA NA 2.2076 2.2142
SM (d18:1/16:0) 0.0577 0.0620 0.0148 0.0125 0.0064 4.2007 4.1442
SM (d18:1/16:1) 0.0400 0.0414 0.0191 0.0170 NA 2.9871 2.8879
SM (d18:1/21:0) NA NA NA NA NA 1.0464 0.9613
SM (d18:2/14:0) NA NA NA NA NA 0.9784 1.0180
SM (d18:2/23:0) 0.0313 0.0305 NA NA NA 2.4246 2.2355
SM (d18:2/24:1) NA NA NA NA NA 1.0147 0.9877
SM (d38:1) 0.1085 0.1102 NA NA NA 2.1498 2.2685
SM (d40:1) 0.0996 0.0976 0.0206 0.0184 0.0081 3.5823 3.5545
SM (d40:2) A 0.0706 0.0693 NA NA NA 2.2461 2.2867
SM (d41:1) 0.1373 0.1204 0.0429 0.0449 NA 2.7840 2.6612
SM (d42:1) 0.0277 0.0249 0.0088 0.0085 NA 3.3239 3.1528
SM (d44:2) NA NA NA NA NA 1.0246 0.9795
TG (14:0/14:0/14:0) 1.8893 1.9487 0.0195 0.0155 NA NA NA
TG (42:0) 0.9943 1.0065 NA NA NA NA NA
TG (42:1) 0.9776 1.0256 NA NA NA NA NA
TG (44:1) 2.5505 2.6319 0.0117 0.0090 NA 0.0015 0.0035
TG (44:2) 1.8353 1.8714 0.0179 0.0154 NA NA NA
TG (46:0) 3.1150 3.1024 0.0181 0.0139 0.0014 0.0082 0.0147
TG (46:1) 3.0021 2.9582 0.0142 0.0112 0.0003 0.0051 0.0117
TG (46:2) 2.6576 2.6503 0.0107 0.0086 NA 0.0022 0.0068
TG (46:3) 1.8361 1.8888 0.0070 0.0069 NA NA NA
TG (48:0) 3.0153 3.1873 0.0209 0.0153 0.0009 0.0237 0.0314
TG (48:1) 3.1585 3.0541 0.0179 0.0139 0.0001 0.0072 0.0157
TG (48:2) 3.0547 3.0313 0.0185 0.0155 0.0002 0.0046 0.0134
TG (48:3) 2.6457 2.6661 0.0103 0.0087 NA 0.0013 0.0054
TG (48:4) 0.9987 1.0015 NA NA NA NA NA
TG (49:0) 1.7719 1.6763 NA NA NA 0.0067 0.0095
TG (49:1) 2.7277 2.5562 0.0124 0.0099 NA 0.0068 0.0158
TG (49:2) 2.6503 2.6478 0.0121 0.0105 NA 0.0056 0.0129
TG (49:3) 1.8226 1.9013 0.0085 0.0084 NA NA NA
TG (50:0) 3.2358 2.9671 0.0164 0.0107 0.0010 0.0083 0.0176
TG (50:1) 3.1699 3.0156 0.0254 0.0183 0.0001 0.0141 0.0257
TG (50:2) 3.1135 3.1039 0.0204 0.0162 0.0001 0.0051 0.0138
TG (50:3) 2.9183 2.9160 0.0139 0.0124 0.0001 0.0017 0.0080
TG (50:4) 2.6585 2.6521 0.0097 0.0085 NA 0.0010 0.0058
TG (50:5) 1.8426 1.8831 0.0060 0.0059 NA NA NA
TG (51:0) 1.0343 0.9608 NA NA NA NA NA
TG (51:1) 2.7591 2.5265 0.0119 0.0092 NA 0.0046 0.0117
TG (51:2) 2.6735 2.6230 0.0119 0.0100 NA 0.0043 0.0127
TG (51:3) 2.6453 2.6613 0.0113 0.0096 NA 0.0024 0.0083
TG (51:4) 1.8533 1.8691 0.0070 0.0068 NA NA NA
TG (52:0) 3.3170 2.8748 0.0102 0.0079 0.0026 0.0140 0.0208
TG (52:1) 2.9027 2.7894 0.0145 0.0091 0.0001 0.0034 0.0117
TG (52:2) 3.1648 3.0286 0.0279 0.0204 0.0001 0.0065 0.0184
TG (52:3) 3.1378 3.0737 0.0259 0.0190 0.0001 0.0013 0.0101
TG (52:4) 3.1724 3.0537 0.0158 0.0132 0.0000 0.0005 0.0065
TG (52:5) 2.7091 2.5953 0.0096 0.0081 NA 0.0008 0.0054
TG (52:6) 1.8380 1.8884 0.0060 0.0059 NA NA NA
TG (53:1) 1.9930 1.7090 0.0080 0.0061 NA NA NA
TG (53:2) 2.7272 2.5513 0.0186 0.0139 NA 0.0047 0.0122
TG (53:3) 2.7038 2.5396 0.0272 0.0223 NA 0.0140 0.0294
TG (53:4) 2.7100 2.5891 0.0102 0.0085 NA 0.0046 0.0070
TG (53:5) 1.0254 0.9710 NA NA NA NA NA
TG (54:1) 3.0501 2.2016 0.0093 0.0058 NA 0.0040 0.0104
TG (54:2) 3.3946 2.7913 0.0183 0.0119 0.0001 0.0028 0.0131
TG (54:3) 3.2499 2.9399 0.0241 0.0176 0.0001 0.0048 0.0176
TG (54:4) 3.2284 2.9759 0.0231 0.0172 0.0001 0.0006 0.0095
TG (54:5) 3.2603 2.9549 0.0151 0.0121 0.0001 0.0005 0.0066
TG (54:6) 2.7811 2.5146 0.0090 0.0072 NA 0.0006 0.0054
TG (54:7) A NA NA 1.1316 1.0225 NA NA 0.6479
TG (54:7) B 1.0438 0.9499 NA NA NA NA NA
TG (55:1) 1.1239 0.8584 NA NA NA NA NA
TG (55:2) 1.0815 0.9068 NA NA NA NA NA
TG (55:3) NA NA 1.0419 0.9511 NA NA NA
TG (55:4) 1.0273 0.9688 NA NA NA NA NA
TG (56:1) 3.0707 2.1647 0.0125 0.0084 NA 0.0088 0.0152
TG (56:2) 3.0495 2.1926 0.0095 0.0063 NA 0.0073 0.0181
TG (56:3) 2.8543 2.4042 0.0141 0.0096 NA 0.0067 0.0229
TG (56:4) 2.7969 2.4860 0.0051 0.0039 NA 0.0058 0.0218
TG (56:5) 1.7995 1.6487 NA NA NA 0.0027 0.0084
TG (56:6) 2.7052 2.5855 0.0083 0.0067 NA 0.0063 0.0205
TG (56:7) 2.6911 2.5910 0.0180 0.0148 NA 0.0054 0.0128
TG (56:8) NA NA NA NA NA 0.6256 1.0749
TG (58:1) 3.0627 2.1394 0.0172 0.0119 NA 0.0254 0.0319
TG (58:10) 1.0085 0.9903 NA NA NA NA NA
TG (58:2) 3.0365 2.0396 0.0120 0.0095 NA 0.0203 0.0314
TG (58:3) 2.9899 2.0808 0.0126 0.0101 NA 0.0208 0.0437
TG (58:4) A 1.9016 1.5014 NA NA NA 0.0132 0.0353
TG (58:5) 1.8132 1.6193 NA NA NA 0.0068 0.0209
TG (58:6) 2.5684 2.4678 0.0081 0.0071 NA 0.0038 0.0106
TG (58:7) 2.6975 2.4370 0.0152 0.0135 NA 0.0080 0.0221
TG (58:8) 1.8003 1.6274 NA NA NA 0.0108 0.0254
TG (58:9) 1.0457 0.9477 NA NA NA NA NA
TG (60:2) 3.0028 2.0736 0.0166 0.0127 NA 0.0238 0.0250
TG (60:3) 2.9501 1.9500 0.0194 0.0171 NA 0.0367 0.0573
TG (60:4) 1.1785 0.7960 NA NA NA NA NA
TG (62:2) 1.1830 0.7909 NA NA NA NA NA
TG (62:3) 1.8794 1.4338 NA NA NA 0.0741 0.0929
TG (62:4) 1.1698 0.8059 NA NA NA NA NA
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Treatment:Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | Time Point:4 hours
F2Treatment:Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | Time Point:4 hours
F3Treatment:Media from Human Adipocytes and SKOV3ip1 OvCa Cells Co-Cultured | Time Point:4 hours
F4Treatment:Media from Human Adipocytes Culturing Only | Time Point:4 hours
F5Treatment:Media from SKOV3ip1 OvCa Cells Culturing Only | Time Point:4 hours
F6Treatment:SKOV3ip1 OvCa cells grown in the ABSENCE of human adipocytes (Control) | Time Point:4 hours
F7Treatment:SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | Time Point:4 hours
  logo